Alfred Altomari

Alfred Altomari is a declared insider at 2 companies; the most frequent names are Agile Therapeutics Inc and INSMED Inc. Between 8 February 2016 and 26 August 2024, the trades on record add up to 11 filings.

The open-market record is one-sided, with 4 purchases worth €77k and not one sale. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants and 1 option exercise.

The median purchase comes to €26k. Of 4 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 26 August 2024, reports a transaction of €38k in Agile Therapeutics Inc. The latest purchase dates back some time: it was published 1,511 days ago, on 29 August 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.